Behrens-Baumann W, Küster M
Abteilung Augenheilkunde, Medizinischen Einrichtungen, Universität, Göttingen.
Klin Monbl Augenheilkd. 1987 Sep;191(3):222-5. doi: 10.1055/s-2008-1050497.
The effect of corticosteroid treatment in addition to antimycotic therapy was studied on the basis of a newly developed keratomycosis model. Forty-eight hours after intracorneal injection of a defined strain of Candida albicans, Amphotericin B drops were administered at one-hour intervals ten times a day. To improve penetration of the drops abrasion of the corneal epithelium was performed every three days. In addition, 4 mg of dexamethasone phosphate was injected subconjunctivally into one eye every two days. The results showed that in this low dosage dexamethasone did not worsen the course of the infection in a single case. On the contrary, there was significantly less neovascularization (p less than 0.05) than in the group not treated with dexamethasone. It therefore appears that combination thereby is the best form of treatment for keratomycosis; this is also supported by clinical observations.
在新建立的角膜真菌病模型基础上,研究了抗真菌治疗联合皮质类固醇治疗的效果。向角膜内注射特定白色念珠菌菌株48小时后,每天10次每隔1小时滴注两性霉素B。为提高滴眼液的穿透力,每3天对角膜上皮进行一次擦伤处理。此外,每两天向一只眼的结膜下注射4mg磷酸地塞米松。结果显示,在这种低剂量下,地塞米松在任何一例中均未使感染病程恶化。相反,与未用地塞米松治疗的组相比,新生血管形成明显减少(p<0.05)。因此,联合治疗似乎是角膜真菌病的最佳治疗方式;这也得到了临床观察的支持。